Covered recipient · General Payments record
KENYA S SHOTWELL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2025
$2,831.27
- Reported across 120 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $301.16 | 15 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $54.83 | 3 |
| Lilly USA, LLC | $39.67 | 2 |
| PFIZER INC. | $36.72 | 2 |
| SANOFI-AVENTIS U.S. LLC | $33.10 | 1 |
| Novo Nordisk AS | $32.12 | 2 |
| DEXCOM, INC. | $27.89 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $20.84 | 1 |
| Xeris Pharmaceuticals, Inc. | $20.64 | 1 |
| Valinor Pharma, LLC | $18.31 | 1 |
| ITI, Inc. | $17.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.63 | 03/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203413122 | CMS |
| ABBVIE INC. | $15.39 | 04/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203413128 | CMS |
| ABBVIE INC. | $24.81 | 07/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203413134 | CMS |
| Aimmune Therapeutics, Inc. | $20.84 | 01/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249661867 | CMS |
| Dexcom, Inc. | $27.89 | 07/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250566732 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17.04 | 03/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241668472 | CMS |
| Lilly USA, LLC | $18.14 | 01/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187211906 | CMS |
| Lilly USA, LLC | $21.53 | 02/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187167701 | CMS |
| Novo Nordisk Inc | $14.95 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189132993 | CMS |
| Novo Nordisk Inc | $17.17 | 03/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188605970 | CMS |
| PFIZER INC. | $16.89 | 02/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230036614 | CMS |
| PFIZER INC. | $19.83 | 12/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230202193 | CMS |
| SANOFI-AVENTIS U.S. LLC | $33.10 | 02/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233717436 | CMS |
| Valinor Pharma, LLC | $18.31 | 01/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248456131 | CMS |
| Xeris Pharmaceuticals, Inc. | $20.64 | 01/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250195561 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.